Fear conditioning, a behavioral model for studying fear-related disorders, is believed to be formed by alterations of synaptic efficacy mediated by changes in synaptic transmission and neuronal morphology in lateral amygdala (LA). Rac GTPase and its downstream effector p21-activated kinase (PAK) are involved in such key neuronal functions. Here we show that optical activation of Rac1 GTPase using photoactivatable form of Rac1 (PA-Rac1) in amygdala led to phosphorylation of PAK and inhibition of long-term but not short-term auditory fear conditioning memory formation. Activation of PA-Rac1 in LA one day after fear conditioning had no effect on long-term fear memory tested 24 hrs after PA-Rac1 activation. Inhibition of PAK in LA by microinjection of the PAK inhibitor IPA-3 30 minutes before fear conditioning enhanced long-term but not short-term fear memory formation. Our results demonstrate that photoactivation of Rac1 GTPase in lateral amygdala impairs fear memory formation. Moreover, Rac1 effector PAK activity during fear conditioning constrains the formation of fear memory in LA. Thus, Rac GTPase and PAK proteins may serve as targets for treatment of fear and anxiety disorders.
EphB2 is involved in enhancing synaptic transmission and gene expression. To explore the roles of EphB2 in memory formation and enhancement, we used a photoactivatable EphB2 (optoEphB2) to activate EphB2 forward signaling in pyramidal neurons in lateral amygdala (LA). Photoactivation of optoEphB2 during fear conditioning, but not minutes afterward, enhanced long-term, but not short-term, auditory fear conditioning. Photoactivation of optoEphB2 during fear conditioning led to activation of the cAMP/Ca responsive element binding (CREB) protein. Application of light to a kinase-dead optoEphB2 in LA did not lead to enhancement of long-term fear conditioning memory or to activation of CREB. Long-term, but not short-term, auditory fear conditioning memory was impaired in mice lacking EphB2 forward signaling (EphB2). Activation of optoEphB2 in LA of EphB2 mice enhanced long-term fear conditioning memory. The present findings show that the level of EphB2 forward signaling activity during learning determines the strength of long-term memory consolidation.
Translation is an elementary cellular process that involves
a large
number of factors interacting in a concerted fashion with the ribosome.
Numerous natural products have emerged that interfere with the ribosomal
function, such as puromycin, which mimics an aminoacyl tRNA and causes
premature chain termination. Here, we introduce a photoswitchable
version of puromycin that, in effect, puts translation under optical
control. Our compound, termed puroswitch, features a
diazocine that allows for reversible and nearly quantitative isomerization
and pharmacological modulation. Its synthesis involves a new photoswitchable
amino acid building block. Puroswitch shows little activity
in the dark and becomes substantially more active and cytotoxic, in
a graded fashion, upon irradiation with various wavelengths of visible
light. In vitro translation assays confirm that puroswitch inhibits translation with a mechanism similar to that of puromycin
itself. Once incorporated into nascent proteins, puroswitch reacts with standard puromycin antibodies, which allows for tracking de novo protein synthesis using western blots and immunohistochemistry.
As a cell-permeable small molecule, puroswitch can be
used for nascent proteome profiling in a variety of cell types, including
primary mouse neurons. We envision puroswitch as a useful
biochemical tool for the optical control of translation and for monitoring
newly synthesized proteins in defined locations and at precise time
points.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.